Notice of Closed Meeting, 66270 [2018-27893]
Download as PDF
<![CDATA[
66270
Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices
OMB approval is requested for three
years. Participation in this information
collection is required as a condition of
cooperative agreement funding. There
are no costs to respondents other than
their time. The total annualized burden
hours are 1,344.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hrs.)
Total burden
(in hrs.)
Form name
WISEWOMAN Awardees ..................
Screening and Assessment and
Lifestyle Program MDEs.
Annual Progress Report ...................
21
2
24
1,008
21
1
16
336
...........................................................
........................
........................
........................
1,344
Total ...........................................
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2018–27855 Filed 12–21–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
E60, Atlanta, Georgia 30333, (404) 718–8833,
gca5@cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2018–27893 Filed 12–21–18; 8:45 am]
Notice of Closed Meeting
BILLING CODE 4163–18–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
amozie on DSK3GDR082PROD with NOTICES1
Number of
responses per
respondent
Type of respondents
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—CK19–002,
Quantifying Contact Rates and Mixing
Patterns in Workers in Non-Healthcare Work
Settings in the United States and CK19–004,
Study to Assess the Risk of Blood Borne
Transmission of Classic Forms of CreutzfeldtJakob Disease (CJD).
Date: May 7, 2019.
Time: 10:00 a.m.–5:00 p.m., (EDT).
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Gregory
Anderson, M.S., M.P.H., Scientific Review
Officer, CDC, 1600 Clifton Road NE, Mailstop
VerDate Sep<11>2014
20:07 Dec 21, 2018
Jkt 247001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–19–0600]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled CDC Model
Performance Evaluation Program
(MPEP) for Mycobacterium tuberculosis
Drug Susceptibility Testing to the Office
of Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on August
28, 2018 to obtain comments from the
public and affected agencies. CDC
received one non-substantive
anonymous comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
CDC Model Performance Evaluation
Program (MPEP) for Mycobacterium
tuberculosis Drug Susceptibility Testing
(OMB Control No.0920–0600, Expires 3/
31/2019)—Revision—National Center
for HIV/AIDS, Viral Hepatitis, STD, and
TB Prevention (NCHHSTP) Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
As part of the continuing effort to
support domestic public health
E:\FR\FM\26DEN1.SGM
26DEN1
]]>Agencies
[Federal Register Volume 83, Number 246 (Wednesday, December 26, 2018)]
[Notices]
[Page 66270]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27893]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Chief Operating
Officer, CDC, pursuant to Public Law 92-463. The grant applications and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP)--CK19-002, Quantifying
Contact Rates and Mixing Patterns in Workers in Non-Healthcare Work
Settings in the United States and CK19-004, Study to Assess the Risk
of Blood Borne Transmission of Classic Forms of Creutzfeldt-Jakob
Disease (CJD).
Date: May 7, 2019.
Time: 10:00 a.m.-5:00 p.m., (EDT).
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600 Clifton Road NE, Mailstop E60,
Atlanta, Georgia 30333, (404) 718-8833, gca5@cdc.gov.
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal
Register notices pertaining to announcements of meetings and other
committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and
Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-27893 Filed 12-21-18; 8:45 am]
BILLING CODE 4163-18-P
